262 related articles for article (PubMed ID: 12970014)
21. [Comparative analysis of the informative value of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in the differential diagnosis of solitary lung masses].
Tlostanova MS; Avetisian AO; Kozak AR
Vestn Rentgenol Radiol; 2014; (3):13-9. PubMed ID: 25782293
[TBL] [Abstract][Full Text] [Related]
22. Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules.
Alkhawaldeh K; Bural G; Kumar R; Alavi A
Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):246-52. PubMed ID: 17938921
[TBL] [Abstract][Full Text] [Related]
23. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
Hübner KF; Buonocore E; Gould HR; Thie J; Smith GT; Stephens S; Dickey J
Clin Nucl Med; 1996 Dec; 21(12):941-9. PubMed ID: 8957608
[TBL] [Abstract][Full Text] [Related]
24. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.
Matthies A; Hickeson M; Cuchiara A; Alavi A
J Nucl Med; 2002 Jul; 43(7):871-5. PubMed ID: 12097455
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: comparative study with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PET.
Ninomiya H; Oriuchi N; Kahn N; Higuchi T; Endo K; Takahashi K; Chikamatsu K; Kamada H; Furuya N
Ann Nucl Med; 2004 Feb; 18(1):29-34. PubMed ID: 15072181
[TBL] [Abstract][Full Text] [Related]
26. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.
Hickeson M; Yun M; Matthies A; Zhuang H; Adam LE; Lacorte L; Alavi A
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399
[TBL] [Abstract][Full Text] [Related]
27. Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET.
Hsu WH; Hsu NY; Shen YY; Yen RF; Kao CH
Cancer Invest; 2003; 21(1):47-52. PubMed ID: 12643009
[TBL] [Abstract][Full Text] [Related]
28. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
[TBL] [Abstract][Full Text] [Related]
29. The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.
Macdonald K; Searle J; Lyburn I
Clin Radiol; 2011 Mar; 66(3):244-50. PubMed ID: 21295203
[TBL] [Abstract][Full Text] [Related]
30. Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
Yanagawa T; Watanabe H; Inoue T; Ahmed AR; Tomiyoshi K; Shinozaki T; Oriuchi N; Endo K; Takagishi K
J Comput Assist Tomogr; 2003; 27(2):175-82. PubMed ID: 12703009
[TBL] [Abstract][Full Text] [Related]
31. [Positron emission tomography using 18-FDG-PET in radiologically indeterminate pulmonary lesions].
Ruiz-Hernández G; de Juan R; Samanes A; Verea H; Peñas JM; Veres A; Lapeña L; Montz R; Carreras JL
An Med Interna; 2004 Jan; 21(1):12-6. PubMed ID: 15195479
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of mycobacterial infections using 18F-fluorodeoxyglucose-positron emission tomography: results of nine cases].
Uruga H; Ishihara M; Hanada S; Takaya H; Miyamoto A; Morokawa N; Fujii T; Kurosaki A; Kishi K
Kekkaku; 2014 Feb; 89(2):39-43. PubMed ID: 24716357
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
Shimizu K; Okita R; Saisho S; Yukawa T; Maeda A; Nojima Y; Nakata M
Ann Nucl Med; 2015 Dec; 29(10):854-60. PubMed ID: 26254228
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of pulmonary lesions with positron emission tomography].
Knopp MV; Bischoff HG
Radiologe; 1994 Oct; 34(10):588-91. PubMed ID: 7816916
[TBL] [Abstract][Full Text] [Related]
36. Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancer.
Hallett WA; Marsden PK; Cronin BF; O'Doherty MJ
Eur J Nucl Med; 2001 Jul; 28(7):919-22. PubMed ID: 11504091
[TBL] [Abstract][Full Text] [Related]
37. The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonary lesions.
Huang YE; Pu YL; Huang YJ; Chen CF; Pu QH; Konda SD; Appelbaum DE
Nucl Med Commun; 2010 Nov; 31(11):945-51. PubMed ID: 20739905
[TBL] [Abstract][Full Text] [Related]
38. [Fluorine-18 fluorodeoxyglucose uptake in patients with primary lung cancer].
Wang T; Sun Y; Zhou N; Yao S; Wang R; Yin D
Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):437-40. PubMed ID: 12139802
[TBL] [Abstract][Full Text] [Related]
39. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
40. Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.
Miyauchi T; Wahl RL
Eur J Nucl Med; 1996 May; 23(5):517-23. PubMed ID: 8698055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
